After a 10-month delay, it looks like we may be getting close to the appointment of a permanent leader of the U.S. Health Resources and Services Administration (HRSA), the federal agency that runs the 340B drug pricing program.
News organization Politico said in its Politico Pulse blog yesterday that White House COVID-19 Testing Coordinator and longtime Washington policy player Carole Johnson will step down soon and is expected to be President Biden’s pick to run HRSA. According to Politico, two people with knowledge of the matter said Johnson is in line for the HRSA job. The news organization said the appointment is not final, and that Johnson does not have a set date for leaving the White House and joining HRSA.
After a 10-month delay, it looks like we may be getting close to the appointment of a permanent leader of the U.S. Health Resources and Services Administration (HRSA), the federal agency that runs the 340B drug pricing program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
